|
2024
|
Invention
|
Aneurysm treatment by exosomes.
The present disclosure provides means of inhibition and/or treat... |
|
|
Invention
|
Generation and utility of b cell subsets for treatment of chronic obstructive pulmonary disease. ... |
|
|
Invention
|
Enhancement of anti-angiogenic cancer immunotherapy by abortogenic agents.
Parallels between pre... |
|
|
Invention
|
Prediction of stem cell therapy responsiveness by quantification of pre-existing b regulatory cel... |
|
|
Invention
|
Enhanced efficacy of tolerogenic vaccination.
Disclosed are means, methods, and compositions of ... |
|
2023
|
Invention
|
Treatment of chronic obstructive pulmonary disease with myeloid derived suppressor cells.
Disclo... |
|
|
Invention
|
Mesenchymal stem cell therapy of epilepsy and seizure disorders.
Disclosed are novel composition... |
|
|
Invention
|
Treatment of bipolar disorder using mesenchymal stem cells and modification of mesenchymal stem c... |
|
|
Invention
|
Treatment of copd by stimulation of stem cell mobilization.
Disclosed are means of inducing pulm... |
|
|
Invention
|
Gene silencing therapy of acute respiratory disorder.
Disclosed are treatment means, composition... |
|
|
Invention
|
Treatment of chronic obstructive pulmonary disease by mesenchymal stem cell apoptotic bodies and ... |
|
|
Invention
|
Gene modified ipsc derived cellular compositions for regeneration and immune modulation.
Disclos... |
|
|
Invention
|
Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell rege... |
|
|
Invention
|
Treatment of trauma associated cognitive dysfunction using mesenchymal stem cell apoptotic bodies... |
|
|
Invention
|
Treatment of covid-19 associated cognitive dysfunction by nutraceutical preparations.
Disclosed ... |
|
2022
|
Invention
|
Umbilical cord derived regenerative and immune modulatory stem cell populations.
The present inv... |
|
|
Invention
|
Induction of concurrent pulmonary immune modulation and regeneration by protein mediated conjugat... |
|
|
Invention
|
Reduction of neutrophil extracellular trap formation by mesenchymal stem cells and their exosomes... |
|
|
Invention
|
Stimulation of mesenchymal stem cell therapeutic activities by t regulatory cells. Disclosed are ... |
|
|
Invention
|
Ivermectin compositions for treatment of covid-19.
Disclosed are novel mechanisms of action of i... |
|
|
Invention
|
Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and ... |
|
|
Invention
|
Enhancement of umbilical cord mesenchymal stem cell therapeutic activity by stimulators of t regu... |
|
|
Invention
|
Induction of neurogenesis using umbilical cord derived mesenchymal stem cells and derivatives the... |
|
|
Invention
|
Treatment of parkinson's disease by immune modulation and regenerative means.
Disclosed are mean... |
|
|
Invention
|
Compositions capable of stimulating immunity towards tumor blood vessels.
Disclosed are novel me... |
|
|
Invention
|
Lithium as a monotherapy and/or stem cell adjuvant therapy for pulmonary fibrosis.
Disclosed are... |
|
|
Invention
|
Immunotherapies for targeting of tumor vasculature.
Disclosed are novel means, protocols, and co... |
|
|
Invention
|
Treatment of major depressive disorder by low dose interleukin-2.
Disclosed are methods, composi... |
|
|
Invention
|
Amelioration and treatment of opioid addiction.
Disclosed are compositions of matter, protocols ... |
|
|
Invention
|
Chimeric cells comprising dendritic cells and endothelial cells resembling tumor endothelium.
Di... |
|
|
Invention
|
Pluripotent stem cell derived dendritic cells and engineered dendritic cells for cancer immunothe... |
|
|
Invention
|
Therapeutic monocytes for prevention of suicidal ideation.
The invention discloses compositions ... |
|
|
Invention
|
Ex vivo generation of immunocytes recognizing brother of the regulator of imprinted sites (boris)... |
|
|
Invention
|
Stimulation of natural kill cell memory by administration of dendritic cells.
Disclosed are mean... |
|
|
Invention
|
Stimulation of dendritic cell activity by homotaurine and analogues thereof.
Disclosed are means... |
|
2021
|
Invention
|
Immunotherapy for opioid addiction.
Disclosed are means, methods and compositions of matter usef... |
|
|
Invention
|
Treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal ... |
|
|
Invention
|
Stimulation of nk cell activity by using a combination of broccoli, nigella sativa, green tea, an... |
|
|
Invention
|
Protection and regeneration of neurological function by using stem cells.
Disclosed are therapeu... |
|
|
Invention
|
Nutraceutical reduction prevention and/or reversion of multiple sclerosis.
Disclosed are composi... |
|
|
Invention
|
Prevention of pathological coagulation in covid-19 and other inflammatory conditions.
The invent... |
|
|
Invention
|
Upregulation of therapeutic t regulatory cells and suppression of suicidal ideations in response ... |
|
|
Invention
|
Methods of determining risk of suicide by immunological assessment.
Disclosed are means and meth... |
|
|
Invention
|
Methods of determining risk of suicide by immunological assessment. ,, and ability of immune cell... |
|
|
Invention
|
Prevention of neuroinflammation associated memory loss using nutraceutical compositions. Nigella ... |
|
|
Invention
|
Neuroprotection and neuroregeneration by pterostilbene and compositions thereof. Disclosed are me... |
|
|
Invention
|
Additive and/or synergistic combinations of metformin with nutraceuticals for the prevention, inh... |
|
|
Invention
|
Augmentation of natural killer cell activity and induction of cytotoxic immunity using leukocyte ... |
|
|
Invention
|
Treatment of covid-19 lung injury using umbilical cord plasma based compositions.
Disclosed are ... |
|
2020
|
Invention
|
Personalized immunotherapies for reduction of brain inflammation and suicide prevention.
Disclos... |
|
|
P/S
|
Medical testing for diagnostic or treatment purposes |
|
|
P/S
|
Dietary supplements |
